Market Place
Sourcing Support
Merck signs up to $2 bln obesity drug deal with biotech Hansoh
18 Dec 2024 //
REUTERS
Merck discontinues development of 2 experimental cancer drugs
18 Dec 2024 //
REUTERS
Merck’s KEYTRUDA® Approved in China for NSCLC Neoadjuvant Treatment
16 Dec 2024 //
BUSINESSWIRE
Merck`s WELIREG® Gets EU Nod For VHL Tumors & Advanced RCC
13 Dec 2024 //
BUSINESSWIRE
Keros shares collapse on ‘unanticipated’ setback for lung drug
12 Dec 2024 //
BIOPHARMADIVE
LYNPARZA Demonstrates Prolonged Survival in Early Breast Cancer
11 Dec 2024 //
BUSINESSWIRE
Merck`s Biologic Keytruda Receives Suppl Approval in US
11 Dec 2024 //
FDA
Merck Manuals: What to Know About Listeria and Recent Recalls
11 Dec 2024 //
PR NEWSWIRE
Merck ADC RORs into phase 3 with 100% complete response rate
10 Dec 2024 //
PRESS RELEASE
Merck`s Zilovertamab Vedotin 100% Response in Phase 2 Lymphoma Trial
08 Dec 2024 //
BUSINESSWIRE
FDA Grants Breakthrough Status to Sac-TMT for EGFR NSCLC
03 Dec 2024 //
BUSINESSWIRE
Biopharma Takes on Deadly Brain Cancer After Decades of Failure
02 Dec 2024 //
BIOSPACE
Kelun-Biotech`s TROP2 ADC Approved in China for Advanced TNBC
27 Nov 2024 //
PR NEWSWIRE
Merck to Participate in Citi 2024 Global Healthcare Conference
26 Nov 2024 //
BUSINESSWIRE
Merck`s therapy for rare lung condition to help reduce risk of death
26 Nov 2024 //
REUTERS
Merck recommends rejection of TRC Capital’s “Mini-Tender” Offer
23 Nov 2024 //
INDPHARMAPOST
US FDA finds widely used asthma drug impacts the brain
23 Nov 2024 //
BIOSPACE
Surendralal Karsanbhai Elected to Merck Board of Directors
22 Nov 2024 //
BUSINESSWIRE
Merck To Participate In 7th Evercore ISI HealthCONx Conference
22 Nov 2024 //
BUSINESSWIRE
Merck Presents Promising Hematology Data at ASH Annual Meeting
21 Nov 2024 //
BUSINESSWIRE
Merck Sharp`s Biologic Keytruda Receives Suppl Approval in US
20 Nov 2024 //
FDA
Merck Foundation Announces $17M Cardiac Care Access Initiative
20 Nov 2024 //
ACCESSWIRE
Merck says Keytruda injection on par with approved IV version in trial
20 Nov 2024 //
FIERCE PHARMA
Merck Announces First-Quarter 2025 Dividend
19 Nov 2024 //
BUSINESSWIRE
Merck signs up to $3.3 billion cancer drug deal with LaNova
16 Nov 2024 //
REUTERS
Merck Receives CHMP Opinion for KEYTRUDA® in MPM
15 Nov 2024 //
BUSINESSWIRE
Merck joins ALA`s pulmonary arterial hypertension awareness push
14 Nov 2024 //
FIERCE PHARMA
Merck Licenses LM-299, Anti-PD-1/VEGF Bispecific Antibody
14 Nov 2024 //
BUSINESSWIRE
Merck to Participate in the Jefferies London Healthcare Conference
14 Nov 2024 //
BUSINESSWIRE
AZ, Merck`s Koselugo delivers trial win in adults with NF1
13 Nov 2024 //
FIERCE PHARMA
BMS, Merck, Amgen & more face near-term generic woes: Leerink
13 Nov 2024 //
FIERCE PHARMA
Merck, AstraZeneca Announce Phase 3 Win for Cancer Drug
12 Nov 2024 //
FIERCE BIOTECH
Merck to Present Gardasil 9 Supporting Gender-Neutral HPV Vaccine
12 Nov 2024 //
BUSINESSWIRE
Koselugo Shows Improve in NF1 Plexiform Neurofibromas in Ph 3 Trial
12 Nov 2024 //
BUSINESSWIRE
Merck to Participate in the UBS Global Healthcare Conference
06 Nov 2024 //
BUSINESSWIRE
Gardasil`s troubles in China haunt Merck in Q3
31 Oct 2024 //
FIERCE PHARMA
Merck Announces Third-Quarter 2024 Financial Results
31 Oct 2024 //
BUSINESSWIRE
Merck, Moderna Launch Phase 3 Trial for NSCLC Treatment
28 Oct 2024 //
BUSINESSWIRE
Sanofi isn`t sweating a potential RSV showdown with Merck
26 Oct 2024 //
FIERCE PHARMA
Merck’s KEYTRUDA® Receives New Approvals For Gynecologic Cancers
24 Oct 2024 //
BUSINESSWIRE
In boon for Pfizer and Merck, CDC panel backs expanded use of vaccines
24 Oct 2024 //
FIERCE PHARMA
Merck buys cancer therapy developer Modifi for up to $1.3 bln
24 Oct 2024 //
REUTERS
Merck-Gilead long-acting oral combo suppresses HIV for 48 weeks
22 Oct 2024 //
FIERCE BIOTECH
Merck`s RSV antibody for infants effective in reducing infections in study
18 Oct 2024 //
REUTERS
Merck’s Clesrovimab Significantly Reduces RSV In Infants
17 Oct 2024 //
BUSINESSWIRE
Merck’s Capvaxine Shows Response In Pneumococcal Disease
16 Oct 2024 //
BUSINESSWIRE
Exelixis And Merck Sign Clinical Development Collaboration
14 Oct 2024 //
BUSINESSWIRE
Merck To Present Vaccine And Infectious Disease Data At IDWeek
09 Oct 2024 //
BUSINESSWIRE
Merck signs $1.9B deal to explore fibroblast therapies
09 Oct 2024 //
FIERCE BIOTECH
Merck`s Keytruda stages comeback in head and neck cancer
08 Oct 2024 //
FIERCE PHARMA
Cerevance Achieves Second Milestone In Merck Collaboration
08 Oct 2024 //
GLOBENEWSWIRE
Merck Immune From Antitrust Claim Over Mumps Vaccine
07 Oct 2024 //
REUTERS
Merck`s Skills-First Program
04 Oct 2024 //
ACCESSWIRE
Merck Schedules Q3 2024 Earnings Conference Call October 31
01 Oct 2024 //
BUSINESSWIRE
Merck Acquires B-Cell Therapy CN201 From Curon Biopharmaceutical
01 Oct 2024 //
BUSINESSWIRE
Merck bags options on Evaxion`s AI-designed vaccine candidates
26 Sep 2024 //
FIERCE BIOTECH
Merck To Present Tulisokibart Data At UEG Week 2024
26 Sep 2024 //
BUSINESSWIRE
Merck’s Keytruda Combo Fails in Phase III Colorectal Cancer Study
26 Sep 2024 //
PRESS RELEASE
Merck`s KEYTRUDA Approved In Japan For NSCLC And Carcinoma
25 Sep 2024 //
BUSINESSWIRE
FDA challenges broad use of PD-1 drugs in stomach cancer
24 Sep 2024 //
FIERCE PHARMA
